Loading clinical trials...
Loading clinical trials...
The Association Between Dietary Choline, Genetics and Anxiety/Depression
The associations between dietary choline, genetics and anxiety/depression
Choline, previously considered to be a vitamin, is an essential nutrient involved in a plethora of biological pathways. Choline status is thought to be associated with depression and anxiety, however, the lack of evidence regarding the exact mechanism of its action warrants further investigation. This study aims to explore the associations between dietary choline and depression and anxiety in healthy individuals and how these may differ according to genetics, specifically Phosphatidylethanolamine N-Methyltransferase gene involved in endogenous and exogenous choline metabolism. Establishing these associations could reinforce the need for future intervention trials that could in turn establish causality and determine the mechanistic effects of dietary choline and the PEMT gene activity on depression/anxiety
Age
18 - 50 years
Sex
ALL
Healthy Volunteers
Yes
St Mary's University
London, United Kingdom
Start Date
August 1, 2019
Primary Completion Date
October 3, 2019
Completion Date
October 3, 2019
Last Updated
July 29, 2019
80
ESTIMATED participants
Lead Sponsor
St Mary's University College
NCT07360600
NCT06793397
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions